| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1531-8257(199901)14:1<155::AID-MDS1026>3.0.CO;2-Z |
| P698 | PubMed publication ID | 9918360 |
| P2093 | author name string | R Kurlan | |
| I H Richard | |||
| A Maughn | |||
| P433 | issue | 1 | |
| P304 | page(s) | 155-157 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series | |
| P478 | volume | 14 |
| Q34934375 | Comorbidity of depression with other medical diseases in the elderly |
| Q33652329 | Consultation-liaison Approach for the Management of Psychiatric Manifestations in Parkinson's Disease and Related Disorders: A Report from Neuropsychiatric Hospital, India |
| Q36022096 | Depression and Parkinson's disease. |
| Q52889176 | Depression in Parkinson's Disease. |
| Q34508166 | Depression in Parkinson's disease |
| Q42235487 | Differential response of speed, amplitude, and rhythm to dopaminergic medications in Parkinson's disease. |
| Q37685695 | Dopamine receptor agonists and depression in Parkinson's disease |
| Q44920810 | Fluoxetine-induced tremor: clinical features in 21 patients. |
| Q63865837 | Influence of initial use of serotonergic antidepressants on antiparkinsonian drug use in levodopa-using patients |
| Q73239126 | Mood Disorders in Neurologic Illness |
| Q64764441 | Neuropsychiatric aspects of Parkinson's disease |
| Q35103472 | Neuropsychiatric aspects of Parkinson's disease: recent advances |
| Q37077360 | Pharmacological treatment of Parkinson's disease: life beyond dopamine D2/D3 receptors? |
| Q83139326 | Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study |
| Q28191314 | Prevalence, etiology, and treatment of depression in Parkinson's disease |
| Q36673715 | Recognition and management of neuropsychiatric complications in Parkinson's disease |
| Q35803990 | Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa |
| Q64972290 | The pharmacologic management of depression in Parkinson's disease. |
| Q73503039 | Worsening of Parkinson's disease by citalopram |
Search more.